CorMedix market cap CRMD

Share price times shares outstanding: what the whole company sells for, since 2011.

CorMedix is worth $611.9M at the close on Oct 23, 2026, at $7.85 a share.

That is down 27% over the last year and up 231% over five years.

Its highest close in our data was $1.1B in Aug 2025.

Market cap over time

Year	End of year	Low	High	Change
2026 so far	$611.9M	$494.1M	$958.1M	−38%
2025	$987.2M	$382M	$1.1B	+98%
2024	$498.2M	$169.9M	$728.4M	+142%
2023	$206.1M	$140.8M	$248.7M	+18%
2022	$174.2M	$110.3M	$278.9M	+1%
2021	$173.3M	$173.3M	$564.9M	−27%
2020	$238.7M	$71.1M	$287.9M	+30%
2019	$183.2M	$124.1M	$220.3M	+37%
2018	$133.7M	$14.7M	$221.1M	+299%
2017	$33.5M	$20.2M	$97M	−46%
2016	$61.9M	$43.5M	$151M	−14%
2015	$71.8M	$43M	$222M	+91%
2014	$37.6M	$24.1M	$45.4M	+95%
2013	$19.2M	$6.8M	$19.2M	+141%
2012	$8M	$1.9M	$8.2M	+150%
2011	$3.2M	$3.2M	$12.8M	n/a

Companies in Drug Manufacturers - General nearest CorMedix's size, closest first, today.

Company	Market cap
CRMDCorMedix	$611.9M
ZVRAZevra Therapeutics	$582.6M
IRWDIronwood Pharmaceuticals	$571.7M
PBYIPuma Biotechnology	$568.9M
COLLCollegium Pharmaceutical	$747.5M
ARVNArvinas	$477.3M
ABUSArbutus Biopharma	$831M
AMPHAmphastar Pharmaceuticals	$1.1B
OMEROmeros	$1.2B
PCRXPacira BioSciences	$1.5B
ANABAnaptysbio	$1.5B
Peer median	$789.2M